
Tuesday, May 10, 2022 10:19:25 AM
Source: TipRanks
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Logicbio Therapeutics (LOGC – Research Report) and ATI Physical Therapy (ATIP – Research Report). Logicbio Therapeutics (LOGC) Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Logicbio Therapeutics yesterday and set a price target of $6.00. The company's shares closed last Monday at $0.67, close to its 52-week low of $0.39. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-logicbio-therapeutics-logc-and-ati-physical-therapy-atip?utm_source=advfn.com&utm_medium=referral
Liked By
Spread the love. Be the first to like this post!
FEATURED SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split • Sep 27, 2023 9:49 AM
FEATURED 1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience • Sep 26, 2023 8:37 AM
Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • BLEG • Sep 26, 2023 10:37 AM
Avant Technologies Reshaping Future of Supercomputing and AI with Disruptive Private Cloud Infrastructure • AVAI • Sep 26, 2023 8:45 AM
Image Protect Announces Debt Forgiveness in Excess of $1,400,000 Clearing the Path for Pending New Business Development • IMTL • Sep 26, 2023 8:16 AM
CGrowth Capital Inc. Nears Key Milestone in Lithium Mining Expansion • CGRA • Sep 26, 2023 8:08 AM